Table 1:

Baseline characteristics for overall trial participants and ultrasound sub-study participants

	Overall Trial			Ultrasound Substudy
	Total1 (N=675)	PCDT (N=325)	Control (N=350)	Total1 (N=126)	PCDT (N=61)	Control (N=65)
Age (years), median (SD)	52.0 (42.0, 62.0)	52.0 (41.0, 61.0)	53.0 (43.0, 62.0)	52.0 (41.0, 59.0)	52.0 (39.0, 57.0)	52.0 (42.0, 62.0)
Male, n (%)	416 (62%)	197 (61%)	219 (63%)	76 (60%)	33 (54%)	43 (66%)
White, n (%)	528 (78%)	257 (79%)	271 (77%)	107 (85%)	54 (89%)	53 (82%)
Hispanic or Latino, n (%)	41 (6%)	15 (5%)	26 (7%)	9 (7%)	3 (5%)	6 (9%)
BMI, median (SD)	30.6 (26.8, 35.7)	30.9 (27.5, 36.0)	30.5 (26.2, 35.1)	31.4 (27.5, 35.6)	31.6 (27.8, 35.5)	31.1 (26.4, 36.4)
eGFR, median (SD)	84.2 (72.0, 98.0)	78.0 (70.0, 97.0)	88.0 (74.0, 102.0)	93.5 (70.0, 108.0)	72.0 (69.0, 97.0)	102.0 (92.0, 116.0)
DVT Left Leg, n (%)	416 (62%)	203 (63%)	213 (61%)	78 (62%)	40 (66%)	38 (59%)
Non-compressible CFV, n (%)	364/644 (57%)	179/308 (58%)	185/336 (55%)	67/122 (55%)	31/58 (53%)	36/64 (56%)
Non-compressible FV, n (%)	598/644 (93%)	286/308 (93%)	312/336 (93%)	116/122 (95%)	53/58 (91%)	63/64 (98%)
Non-compressible PV, n (%)	554/643 (86%)	267/308 (87%)	287/335 (86%)	108/121 (89%)	48/58 (83%)	60/63 (95%)

¹Treatment groups are per-protocol patients

BMI=Body Mass Index, eGFR=Estimated Glomerular Filtration Rate, DVT=Deep Vein Thrombus, CFV=Common Femoral Vein, FV=Femoral Vein, PCDT=Pharmacomechanical Catheter-Directed Thrombolysis, PV=Popliteal Vein, SD=Standard Deviation